<DOC>
	<DOCNO>NCT02147054</DOCNO>
	<brief_summary>Organophosphate pesticide poison cause close 300 000 death per year worldwide . Many patient ingest organophosphate require ventilation ; patient approximately 50 % die . Much mortality ventilate patient secondary intermediate syndrome . This OP pesticides inhibit acetylcholinesterase , cause excess acetylcholine nerve synapsis neuromuscular junction ( NMJ ) . At NMJ , excess acetylcholine cause overstimulation damage , may lead sudden respiratory arrest prolong ventilation associate complication . The investigator believe block receptor use neuromuscular block agent Rocuronium protect NMJ damage thus prevent intermediate syndrome reduce number intubate day mortality . In pilot randomise control trial Rocuronium , competitive nicotinic receptor antagonist , use bind receptor neuromuscular junction block effect accumulate acetylcholine . The effect OP pesticide cholinesterase blood monitor Rocuronium withdrawn use Sugammadex OP eliminate body .</brief_summary>
	<brief_title>A Pilot Study Using Rocuronium Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning</brief_title>
	<detailed_description>Primary outcome : Number day intubate</detailed_description>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Organophosphate Poisoning</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>Inclusion criterion : Male female Age 16 Clinical diagnosis OP insecticide poison Admission Intensive Care Unit Ventilation Informed consent family Train four measurement &gt; 50 % Exclusion criterion : Age 16 Pregnant Consent obtain patient patient 's family</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Organophosphate poisoning</keyword>
	<keyword>Intermediate syndrome</keyword>
	<keyword>Rocuronium</keyword>
</DOC>